expanded
-
Biologics
HippoFi Begins 2023 with Strong Sales of Advanced Biomaterials
Expanded sales force fuels market growth. IRVINE, CA., January 13, 2023 /OrthoSpineNews/ – HippoFi, Inc. (formerly ORHub), (OTC Pink: ORHB),…
Read More » -
Regulatory
SI-BONE, Inc. Announces FDA Clearance for Expanded Rod Compatibility with the iFuse Bedrock Granite® Implant System
New Indications Include Use with a Broad Class of Commercially Available Rods SANTA CLARA, Calif., Dec. 27, 2022 (GLOBE NEWSWIRE)…
Read More » -
Biologics
Mg OSTEOINJECT from Bone Solutions Receives 510(k) Clearance for Expanded Indications
Colleyville, TX, July 13, 2022 /OrthoSpineNews/— Bone Solutions Inc. (BSI), an orthobiologics technology company located in Colleyville, Texas, announced today that it has…
Read More » -
Biologics
Kuros Biosciences’s MagnetOs Granules Cleared by FDA for Expanded Spinal Indications
Rare clearance for bone graft for standalone use in spine based on human clinical dataClearance attained with evidence from Level…
Read More » -
Hospitals
Spineology® Announces Expanded FDA Clearance of Elite™ Expandable Interbody Fusion System
March 13, 2017 MINNEAPOLIS & ST. PAUL, Minn.–(BUSINESS WIRE)–Spineology, Inc. the innovator in Anatomy-Conserving Surgery™, is excited to announce expanded…
Read More » -
Hospitals
Zimmer Biomet Announces FDA Approval of Expanded 26-week Efficacy Claim for Gel-One® Cross-Linked Hyaluronate for Treatment of Pain Associated with Knee Osteoarthritis
WARSAW, Ind., Feb. 1, 2017 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that the U.S. Food…
Read More » -
Financial
Episurf Medical receives expanded reimbursement coverage in the UK, Netherlands and Belgium
In line with Episurf Medical’s plan to achieve private health sector reimbursement, the Episealer® procedure and products have been approved…
Read More »